Clinical Trial Update: A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy [Phase 2]

View source ↗

Summary

This is a Phase 2 study of UCB0942 in adults with highly drug-resistant focal epilepsy; the trial has completed and results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Epilepsy

Drugs mentioned

• UCB0942

Snippet

Sponsor: UCB Biopharma S.P.R.L. | Conditions: Highly Drug-resistant Focal Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2019-02-05